Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
- Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
- Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
- Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
...eatment...
...of Platelet ProductsPlatelets for...
...of Rh AlloimmunizationUPDATED. Prevention...
...oreductionUPDATED. The incidence of alloantibod...
...Therapeutic Platelet TransfusionPro...
...fusion Threshold in Patients with Hematologic Mal...
...t Transfusion Threshold in the Settin...
...sfusion in Patients with Chronic, Stabl...
...latelet Transfusion Threshold in Patients With Sol...
...Count at which Surgical or Invasi...
...for Refractoriness to Platelet Transf...
...naging Refractoriness to Platelet Transf...